-
1
-
-
0033169086
-
Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy
-
Balzarini J (1999) Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy. Biochemistry & Pharmacology 58:1-27.
-
(1999)
Biochemistry & Pharmacology
, vol.58
, pp. 1-27
-
-
Balzarini, J.1
-
2
-
-
0033921632
-
In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-β-D-dioxolane-guanosine and suppress resistance to 3′-azido-3′-deoxythymidine
-
Bazmi HZ, Hammond J, Cavalcanti SCH, Chu CK, Schinazi RF & Mellors JW (2000) In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-β-D-dioxolane-guanosine and suppress resistance to 3′-azido-3′-deoxythymidine. Antimicrobial Agents & Chemotherapy 44:1783-1788.
-
(2000)
Antimicrobial Agents & Chemotherapy
, vol.44
, pp. 1783-1788
-
-
Bazmi, H.Z.1
Hammond, J.2
Cavalcanti, S.C.H.3
Chu, C.K.4
Schinazi, R.F.5
Mellors, J.W.6
-
3
-
-
0034685037
-
Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA panel
-
Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schecter M, Schooley RT, Thompson MA, Vella S, Yeni PG, & Volberding PA (2000) Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA panel. Journal of the American Medical Association 283:381-390.
-
(2000)
Journal of the American Medical Association
, vol.283
, pp. 381-390
-
-
Carpenter, C.C.1
Cooper, D.A.2
Fischl, M.A.3
Gatell, J.M.4
Gazzard, B.G.5
Hammer, S.M.6
Hirsch, M.S.7
Jacobsen, D.M.8
Katzenstein, D.A.9
Montaner, J.S.10
Richman, D.D.11
Saag, M.S.12
Schecter, M.13
Schooley, R.T.14
Thompson, M.A.15
Vella, S.16
Yeni, P.G.17
Volberding, P.A.18
-
4
-
-
0033933688
-
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: The OzCombo 1 study
-
Carr A., Chuah J, Hudson J, French M, Hoy J, Law M, Sayer D, Emery S, & Cooper D (2000) A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo 1 study. AIDS 14:1171-1180.
-
(2000)
AIDS
, vol.14
, pp. 1171-1180
-
-
Carr, A.1
Chuah, J.2
Hudson, J.3
French, M.4
Hoy, J.5
Law, M.6
Sayer, D.7
Emery, S.8
Cooper, D.9
-
5
-
-
0001822944
-
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine
-
Coakley EP, Gillis JM & Hammer SM (2000) Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. AIDS 14:F9-F15.
-
(2000)
AIDS
, vol.14
-
-
Coakley, E.P.1
Gillis, J.M.2
Hammer, S.M.3
-
6
-
-
0035158709
-
Establishment of new transmissible and drug sensitive human immunodeficiency virus type I wilt types due to transmission of nucleoside analogue-resistant virus
-
De Ronde A, van Dooren M, van der Hoek L, Bouwhuis D, de Rooij E, van Gemin B, de Boer R & Goudsmit J (2001) Establishment of new transmissible and drug sensitive human immunodeficiency virus type I wilt types due to transmission of nucleoside analogue-resistant virus. Journal of Virology 75:595-602.
-
(2001)
Journal of Virology
, vol.75
, pp. 595-602
-
-
De Ronde, A.1
Van Dooren, M.2
Van der Hoek, L.3
Bouwhuis, D.4
De Rooij, E.5
Van Gemin, B.6
De Boer, R.7
Goudsmit, J.8
-
7
-
-
12444267896
-
Cellular pharmacology of D-d4FC, a nucleoside analog active against drug-resistant HIV
-
Erickson-Viitanen S, Wu JT, Shi G, Unger S, King R, Fish B, Klabe R, Geleziunas R, Gallagher K, Otto MJ & Schinazi RF (2003) Cellular pharmacology of D-d4FC, a nucleoside analog active against drug-resistant HIV. Antiviral Chemistry & Chemotherapy 14:39-47.
-
(2003)
Antiviral Chemistry & Chemotherapy
, vol.14
, pp. 39-47
-
-
Erickson-Viitanen, S.1
Wu, J.T.2
Shi, G.3
Unger, S.4
King, R.5
Fish, B.6
Klabe, R.7
Geleziunas, R.8
Gallagher, K.9
Otto, M.J.10
Schinazi, R.F.11
-
8
-
-
0028300765
-
Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells
-
Gao W-Y, Agbaria R, Driscoll JS & Mitsuya H (1994) Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. Journal of Biological Chemistry 269:12633-12638.
-
(1994)
Journal of Biological Chemistry
, vol.269
, pp. 12633-12638
-
-
Gao, W.-Y.1
Agbaria, R.2
Driscoll, J.S.3
Mitsuya, H.4
-
9
-
-
0142100752
-
The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain terminated DNA synthesis
-
Gotte M, Arion D, Parniak MA & Wainberg MA (2000) The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain terminated DNA synthesis. Journal of Virology 74:3579-3585.
-
(2000)
Journal of Virology
, vol.74
, pp. 3579-3585
-
-
Gotte, M.1
Arion, D.2
Parniak, M.A.3
Wainberg, M.A.4
-
10
-
-
12444260103
-
Structural features of nucleoside analog reverse transcriptase inhibitors important in selection of resistance mutations in HIV-1 reverse transcriptase
-
Scottsdale, Ariz., USA, June 4-9, 2001
-
Hammond JL, Schinazi RF, Chu CK & Mellors JW (2001) Structural features of nucleoside analog reverse transcriptase inhibitors important in selection of resistance mutations in HIV-1 reverse transcriptase. 5th International Workshop on HIV Drug Resistance & Treatment Strategies, Scottsdale, Ariz., USA, June 4-9, 2001.
-
(2001)
5th International Workshop on HIV Drug Resistance & Treatment Strategies
-
-
Hammond, J.L.1
Schinazi, R.F.2
Chu, C.K.3
Mellors, J.W.4
-
11
-
-
17544391491
-
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V
-
Hertogs K, Bloor S, DeVroey V, van Den Eynde C, Dehertogh P, van Cauwenberge A, Sturmer M, Alcorn T, Wegner S, van Houtte M, Miller V & Larder BA (2000) A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V. Antimicrobial Agents & Chemotherapy 44:568-573.
-
(2000)
Antimicrobial Agents & Chemotherapy
, vol.44
, pp. 568-573
-
-
Hertogs, K.1
Bloor, S.2
DeVroey, V.3
Van Den Eynde, C.4
Dehertogh, P.5
Van Cauwenberge, A.6
Sturmer, M.7
Alcorn, T.8
Wegner, S.9
Van Houtte, M.10
Miller, V.11
Larder, B.A.12
-
12
-
-
0001812073
-
Resistance to antiretroviral drugs - An emerging problem
-
Hirsch MS (1998) Resistance to antiretroviral drugs - an emerging problem. AIDS 12:6-7.
-
(1998)
AIDS
, vol.12
, pp. 6-7
-
-
Hirsch, M.S.1
-
13
-
-
0031022510
-
Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild types and protease inhibitor resistant mutants of HIV
-
Jadhav P K, Ala P, Woerner FJ, Chang CH, Garber S, Anton EA & Bacheler LT (1997) Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild types and protease inhibitor resistant mutants of HIV. Journal of Medical Chemistry 40:181-190.
-
(1997)
Journal of Medical Chemistry
, vol.40
, pp. 181-190
-
-
Jadhav, P.K.1
Ala, P.2
Woerner, F.J.3
Chang, C.H.4
Garber, S.5
Anton, E.A.6
Bacheler, L.T.7
-
14
-
-
0035371314
-
Vertical transmission of multidrug resistant human immunodeficiency virus type 1 (HIV-2) and continued evolution of drug resistance in an HIV-1 infected infant
-
Johnson VA, Petropoulos CJ, Woods CR, Hazelwood JD, Parkin NT, Hamilton CD & Fiscus SA (2001) Vertical transmission of multidrug resistant human immunodeficiency virus type 1 (HIV-2) and continued evolution of drug resistance in an HIV-1 infected infant. Journal of Infectious Diseases 183:1688-1693.
-
(2001)
Journal of Infectious Diseases
, vol.183
, pp. 1688-1693
-
-
Johnson, V.A.1
Petropoulos, C.J.2
Woods, C.R.3
Hazelwood, J.D.4
Parkin, N.T.5
Hamilton, C.D.6
Fiscus, S.A.7
-
15
-
-
0035173806
-
Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents
-
Lee K & Chu CK (2001) Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents. Antimicrobial Agents & Chemotherapy 45:138-144.
-
(2001)
Antimicrobial Agents & Chemotherapy
, vol.45
, pp. 138-144
-
-
Lee, K.1
Chu, C.K.2
-
16
-
-
0034456474
-
Resistance against reverse transcriptase inhibitors
-
O'Brien WA (2000) Resistance against reverse transcriptase inhibitors. Clinical Infectious Diseases Suppl. 2:185-192
-
(2000)
Clinical Infectious Diseases
, Issue.SUPPL. 2
, pp. 185-192
-
-
O'Brien, W.A.1
-
17
-
-
0032192444
-
Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies
-
Pastor-Anglada M, Felipe A & Casado FJ (1998) Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies. Trends in Pharmaceutical Sciences 19:424-430.
-
(1998)
Trends in Pharmaceutical Sciences
, vol.19
, pp. 424-430
-
-
Pastor-Anglada, M.1
Felipe, A.2
Casado, F.J.3
-
18
-
-
0034019566
-
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
-
Petropoulos CJ, Parkin NT, Limoli KL, Lie YS, Wrin T, Huang W, Tian H, Smith D, Winslow GA, Capon DJ & Whitcomb JM (2000) A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrobial Agents & Chemotherapy 44:920-928.
-
(2000)
Antimicrobial Agents & Chemotherapy
, vol.44
, pp. 920-928
-
-
Petropoulos, C.J.1
Parkin, N.T.2
Limoli, K.L.3
Lie, Y.S.4
Wrin, T.5
Huang, W.6
Tian, H.7
Smith, D.8
Winslow, G.A.9
Capon, D.J.10
Whitcomb, J.M.11
-
19
-
-
0003710791
-
Second generation NNRTIs require multiple mutations for selection of highly resistant HIV in vitro
-
Durban, South Africa, July 7-12, 2000. Abstract #A347
-
Rayner MM, Garber S, Logue K, Corbett J, Baker D, Lukac S, Powell D, Bacheler L & Erickson-Viitanen S (2000) Second generation NNRTIs require multiple mutations for selection of highly resistant HIV in vitro. 13th International Conference on AIDS, Durban, South Africa, July 7-12, 2000. Abstract #A347.
-
(2000)
13th International Conference on AIDS
-
-
Rayner, M.M.1
Garber, S.2
Logue, K.3
Corbett, J.4
Baker, D.5
Lukac, S.6
Powell, D.7
Bacheler, L.8
Erickson-Viitanen, S.9
-
20
-
-
0034083833
-
Mutations in retroviral genes associated with drug resistance: 2000-2001 Update
-
Schinazi RF, Larder BA & Mellors JW (2001) Mutations in retroviral genes associated with drug resistance: 2000-2001 update. International Antiviral News 8:65-81.
-
(2001)
International Antiviral News
, vol.8
, pp. 65-81
-
-
Schinazi, R.F.1
Larder, B.A.2
Mellors, J.W.3
-
21
-
-
0036232997
-
DPC 817: A cytidine nucleoside, analog with activity against zidovudine-and lamivudineresistant viral variants
-
Schinazi RF, MeUors J, Bazmi H, Diamond S, Garber S, Gallagher K, Geleziunas R, Klabe R, Pierce M, Rayner M, Wu JT, Zhang H, Hammond J, Bacheler L, Manion DJ, Otto MJ, Stuyver L, Trainor G, Liotta DC & Erickson-Viitanen S (2002) DPC 817: a cytidine nucleoside, analog with activity against zidovudine-and lamivudineresistant viral variants. Antimicrobial Agents & Chemotherapy 46:1394-1401.
-
(2002)
Antimicrobial Agents & Chemotherapy
, vol.46
, pp. 1394-1401
-
-
Schinazi, R.F.1
MeUors, J.2
Bazmi, H.3
Diamond, S.4
Garber, S.5
Gallagher, K.6
Geleziunas, R.7
Klabe, R.8
Pierce, M.9
Rayner, M.10
Wu, J.T.11
Zhang, H.12
Hammond, J.13
Bacheler, L.14
Manion, D.J.15
Otto, M.J.16
Stuyver, L.17
Trainor, G.18
Liotta, D.C.19
Erickson-Viitanen, S.20
more..
-
22
-
-
0036001225
-
Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry
-
Shi G, Wu JT, Li Y, Geleziunas R, Gallagher K, Emm T, Olah T & Unger S (2002) Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 16:1092-1099.
-
(2002)
Rapid Communications in Mass Spectrometry
, vol.16
, pp. 1092-1099
-
-
Shi, G.1
Wu, J.T.2
Li, Y.3
Geleziunas, R.4
Gallagher, K.5
Emm, T.6
Olah, T.7
Unger, S.8
-
23
-
-
0035876456
-
Phenotypic hypersusceptibiity to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: Impact on virological response to efavirenz-based therapy
-
Shulman N, Zolopa AR, Passaro D, Shafer RW, Huang W, Katzenstein D, Israelski DM, Hellmann N, Petropolos C & Whitcomb J (2001) Phenotypic hypersusceptibiity to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy. AIDS 15:1125-1132.
-
(2001)
AIDS
, vol.15
, pp. 1125-1132
-
-
Shulman, N.1
Zolopa, A.R.2
Passaro, D.3
Shafer, R.W.4
Huang, W.5
Katzenstein, D.6
Israelski, D.M.7
Hellmann, N.8
Petropolos, C.9
Whitcomb, J.10
-
24
-
-
0027464122
-
Synthesis and anti-HIV activity of a series of 2-indolinones and related analogs
-
Smallheer JM, Otto MJ, Amarl-Ly CA, Earl RA, Myers MJ, Pennev P, Montefiori DC & Wuonola MA (1993) Synthesis and anti-HIV activity of a series of 2-indolinones and related analogs. Antiviral Chemistry & Chemotherapy 4:27-39.
-
(1993)
Antiviral Chemistry & Chemotherapy
, vol.4
, pp. 27-39
-
-
Smallheer, J.M.1
Otto, M.J.2
Amarl-Ly, C.A.3
Earl, R.A.4
Myers, M.J.5
Pennev, P.6
Montefiori, D.C.7
Wuonola, M.A.8
-
25
-
-
0031798147
-
Pharmacological considerations in antiretroviral therapy
-
Sommadossi JP (1998) Pharmacological considerations in antiretroviral therapy. Antiviral Therapy 3:9-12.
-
(1998)
Antiviral Therapy
, vol.3
, pp. 9-12
-
-
Sommadossi, J.P.1
-
26
-
-
0033576816
-
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
-
Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, Stryker R, Johnson P, Labriola DF, Farina D, Manion DJ & Ruiz NM (1999) Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. New England Journal of Medicine 341:1865-1873.
-
(1999)
New England Journal of Medicine
, vol.341
, pp. 1865-1873
-
-
Staszewski, S.1
Morales-Ramirez, J.2
Tashima, K.T.3
Rachlis, A.4
Skiest, D.5
Stanford, J.6
Stryker, R.7
Johnson, P.8
Labriola, D.F.9
Farina, D.10
Manion, D.J.11
Ruiz, N.M.12
-
27
-
-
0035174783
-
Phosphorylation of nucleoside analog antiretrovirals: A review for clinicians
-
Stein DS & Moore KHP (2001) Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians. Pharmacotherapy 21:11-34.
-
(2001)
Pharmacotherapy
, vol.21
, pp. 11-34
-
-
Stein, D.S.1
Moore, K.H.P.2
-
28
-
-
0033914679
-
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
-
Van Vaerenbergh K,Van Laethem K, Albert J, Boucher CA, Clotet B, Floridia M, Gerstoft J, Hejdeman B, Nielsen C, Pannecouque C, Perrin L, Pirillo MF, Ruiz L, Schmit JC, Schneider F, Schoolmeester A, Schurman R, Stellbrink HJ, Stuyver L, Van Lunzen J, Van Remoortel B, Van Wijngaerden E, Vella S, Witvrouw M, Yerly S, DeClercq E, Destmyer J & Vandamme AM (2000) Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrobial Agents & Chemotherapy 44:2109-2117.
-
(2000)
Antimicrobial Agents & Chemotherapy
, vol.44
, pp. 2109-2117
-
-
Van Vaerenbergh, K.1
Van Laethem, K.2
Albert, J.3
Boucher, C.A.4
Clotet, B.5
Floridia, M.6
Gerstoft, J.7
Hejdeman, B.8
Nielsen, C.9
Pannecouque, C.10
Perrin, L.11
Pirillo, M.F.12
Ruiz, L.13
Schmit, J.C.14
Schneider, F.15
Schoolmeester, A.16
Schurman, R.17
Stellbrink, H.J.18
Stuyver, L.19
Van Lunzen, J.20
Van Remoortel, B.21
Van Wijngaerden, E.22
Vella, S.23
Witvrouw, M.24
Yerly, S.25
DeClercq, E.26
Destmyer, J.27
Vandamme, A.M.28
more..
-
29
-
-
0029792465
-
Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266
-
Winslow DL, Garber S, Reid C, Scarnati H, Baker D, Rayner MM & Anton ED (1996) Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266. AIDS 10:1205-1209.
-
(1996)
AIDS
, vol.10
, pp. 1205-1209
-
-
Winslow, D.L.1
Garber, S.2
Reid, C.3
Scarnati, H.4
Baker, D.5
Rayner, M.M.6
Anton, E.D.7
-
30
-
-
0028988566
-
Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors
-
Winslow DL, Stack S, King R, Scarnati H, Bincsik A & Otto MJ (1995) Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors. AIDS Research & Human Retroviruses 11:107-113.
-
(1995)
AIDS Research & Human Retroviruses
, vol.11
, pp. 107-113
-
-
Winslow, D.L.1
Stack, S.2
King, R.3
Scarnati, H.4
Bincsik, A.5
Otto, M.J.6
|